Clinical Trial Update: IRIS Ultimaster Cohort in the IRIS-DES Registry

View source ↗

Summary

Clinical trial update reports outcomes from the IRIS Ultimaster cohort within the IRIS-DES registry for patients with coronary artery disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Ultimaster Sirolimus-Eluting Stent (sirolimus-eluting stent)

Snippet

Sponsor: Duk-Woo Park, MD | Conditions: Coronary Artery Disease | Status: COMPLETED